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Abstract: Metastasis to the paranasal sinuses from lung cancer is
extremely rare. Here, we reported a patient of lung adenocarci-
noma presenting with nasion swelling because of metastasis to
the paranasal sinuses. A review of the literature from 1966 to
2008 yielded another 15 patients. Adenocarcinoma was the most
commonly encountered histologic subtype, and modern combi-
nation chemotherapy was probably the most effective treatment
modality. Headache, visual disturbance, facial mass, and facial
pain were the symptoms frequently associated with paranasal
sinus metastasis; however, all of them were nonspecific for a
metastatic tumor. A thorough history taking, ear, nose, and throat
examination, and laboratory investigations are of paramount
importance to achieve a correct diagnosis.
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Lung cancer has a propensity to metastasize widely. How-ever, metastasis to the paranasal sinuses is rare and only
few cases have been reported. We presented here an unusual
case of nasion swelling because of extensive metastasis to the
paranasal sinuses as the presenting symptom of lung adeno-
carcinoma. We also reviewed the published literature and
summarized the clinical features of lung cancer patients with
paranasal sinus metastasis (Table 1).
CASE REPORT
The 59-year-old lady, a housewife and nonsmoker,
visited our hospital for nasion swelling, which had been
enlarging slowly for 3 months. She also had mild nasal
stuffiness and numbness over the right infraorbital region.
Physical examination revealed the bulged nasion (Figure
1A) and slightly impaired superficial sensation in the
territory of the second division of the right trigeminal
nerve. A computed tomography (CT) scan showed a large
ill-defined tumor with involvement of the frontal, ethmoid,
sphenoid, and maxillary sinuses (Figure 2A). The tumor
also invaded the orbits, intracranial cavity, nasal cavity,
and skull base. Under the impression of sinonasal cancer,
the patient underwent an endoscopic biopsy of the ethmoid
sinus. Unexpectedly, the histologic findings showed an
adenocarcinoma, and the cancer cells were immunohisto-
chemically positive for thyroid transcription factor-1 and
cytokeratin 7, but negative for thyroglobulin and cytoker-
atin 20. A CT scan of the chest demonstrated a lung tumor
measured 32 mm in diameter over the lingual segment of
the left upper lobe, and a bronchoscopic biopsy of the
lingual bronchus also revealed a thyroid transcription fac-
tor-1 expressing adenocarcinoma. The final diagnosis was
a stage IV lung adenocarcinoma of the left upper lobe with
extensive paranasal sinus metastasis. After three courses of
combination chemotherapy with gemcitabine and cisplatin,
the nasion swelling almost resolved (Figure 1B) and her
nasal stuffiness and right facial numbness also subsided.
The follow-up CT scan revealed nearly complete resolu-
tion of the sinonasal tumor (Figure 2B). At the time of
writing, the sixth cycle of combination chemotherapy is
being commenced.
DISCUSSION
A review of the world literature between 1966 and
2008 yielded only 16 cases of lung cancer with metastasis
to the paranasal sinuses.1–13 Adenocarcinoma (nine cases)
was the most commonly reported histology, followed by
small cell carcinoma (four cases). Of the 16 patients, the
presenting symptoms were headache in seven, visual dis-
turbance in five, facial mass in three, and facial pain in
three. Involvement of the cranial nerves II, III, IV, and VI
was the leading cause of visual impairment and occurred
exclusively in patients with metastasis to the sphenoid
sinus.5,7,9,11 The proximity of the sphenoid sinus to these
vulnerable nervous structures forms the basis of the oph-
thalmologic abnormalities. Paralysis of the abducens nerve
was more common than any of the others innervating the
extraocular muscles.5,7,9,11 In the majority of the cases (14
of 16 cases), the metastatic tumor involved only one of the
paranasal sinuses: the sphenoid sinus in five, maxillary
sinus in five, frontal sinus in three, and ethmoid sinus in
one. Headache and visual disturbance were the most
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common symptoms associated with sphenoid sinus in-
volvement and metastasis to the frontal sinus frequently
presented with a mass in the frontal area. Maxillary sinus
metastasis might present with epistaxis, facial pain, and
proptosis. There were only two patients with involvement
of two or more of the paranasal sinuses, including the case
presented here, in whom extensive infiltration of all four sinuses
by the malignancy was observed. Symptoms referable to the
TABLE 1. Reported Cases of Lung Cancer with Paranasal Sinus Metastasis, 1966–2008
Year Author Age/Sex Involved Sinus
Symptom of Paranasal Sinus
Metastasis
1966 Bernstein et al.1 48/F Frontal Pain and swelling over left eyea
1968 Morgenstein et al.2 65/M Maxillary Epistaxis, periorbital pain,
exophthalmosa
1971 Jortay et al.3 NR Ethmoid NR
1972 Carruth et al.4 66/F Maxillary Proptosis, loss of visiona
1973 Van Wart et al.5 NR/F Sphenoid Headachea
1974 Inalsingh et al.6 67/M Maxillary Cheek pain
1979 Barrs et al.7 61/M Sphenoid Diplopia, headachea
1985 Kent et al.8 81/M Maxillary Cheek swelling, mouth bleedinga
1990 Mickel et al.9 51/F Sphenoid, ethmoid Ophthalmoplegia, ptosis
71/F Sphenoid Headache, diplopia, decreased
visual acuitya
47/M Sphenoid Headache, facial paina
1992 Ii et al.10 36/M Maxillary Epistaxia, nasal obstruction
1998 Xu et al.11 NR Sphenoid Headache, visual lossa
2002 Clarkson et al.12 79/F Frontal Frontal mass, headache, blurred
vision, nasal dischargea
2005 Rombaux et al.13 71/M Frontal Frontal mass, headachea
2008 Huang et al. (present report) 59/F Frontal, ethmoid, sphenoid,
maxillary
Nasion swelling, nasal stuffiness,
facial numbnessa
Cranial Nerve
Involvement Method of Treatment
Treatment
Effect
Outcome (survival or follow-up
period after presence of
paranasal metastasis) Histological Subtype
— XRT NR NR Adenocarcinoma
— XRT No effect Died (5 mo) Squamous cell carcinoma
C/T No effect
NR NR NR NR Adenocarcinoma
— XRT No effect Died (3 mo) Small cell carcinoma
VI XRT Symptom
improved
Died (1 yr) adenocarcinoma
— XRT Lesion resolved NR (7 mo) Small cell carcinoma
III, IV, VI — — Died (1 wk) Small cell carcinoma
— XRT NR Died (19 mo) Small cell carcinoma
II, III, IV, VI — — Died (1 wk) Poorly differentiated carcinoma
II, VI — — Died (5.5 mo) Adenocarcinoma
III, IV, VI XRT Symptom
improved
Died (7 mo) Adenocarcinoma
C/T No effect
— C/T No effect Died (3 mo) Adenocarcinoma
II, III, IV, V, VI Surgery No effect Died (2 mo) NR
— XRT NR NR Adenocarcinoma
— C/T Tumor volume
decreased




a The symptoms of paranasal sinusmetastasis were the presenting symptoms of lung cancer.
F, female; M, male; NR, not reported; XRT, radiotherapy; C/T, chemotherapy.
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paranasal sinus lesions were the presenting symptoms of lung
cancer in most of the patients.1,2,4,5,7–9,11–13
Eight of the 16 patients underwent radiotherapy to
the paranasal sinuses,1,2,4 –6,8,9,12 and improvement of as-
sociated symptoms or decrease of the tumor volume was
reported in three.5,6,9 Five patients received chemotherapy,
which was effective only in one adenocarcinoma patient13
and ours, and both patients were treated with modern
combination chemotherapy (gemcitabine and cisplatin).
The mean survival time after the presence of paranasal
sinus metastasis was 5.7 months (range, 1 week to 19
months), and death was always associated with widespread
malignancy.
In summary, adenocarcinoma is the most common
histologic subtype of lung cancer with metastasis to the
paranasal sinuses. There are no clinical or radiologic features
that are characteristic in differentiating metastatic tumors
from primary malignancy of the sinuses. For encountering the
tumors at these sites, a thorough clinical and laboratory
investigation should be performed for other primary malig-
nancies, particularly the lung.
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FIGURE 1. A, At first examination,
the photograph revealed a swelling
at the nasion. B, After three cycles of
chemotherapy, the photograph
showed nearly complete resolution
of the swelling.
FIGURE 2. A, The axial section of
head computed tomography before
treatment for lung cancer showed
that a large ill-defined mass (arrows)
involves the paranasal sinuses. B, Af-
ter three cycles of chemotherapy,
the sinonasal mass almost disap-
peared.
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ERRATUM
In the article “Detection and Localization of Intraepithelial Neoplasia and Invasive Carcinoma Using Fluorescence-Reflectance Bronchoscopy: An
International, Multicenter Clinical Trial,” which appeared in volume 4 of Journal of Thoracic Oncology on pages 49–54, an author’s name was
inadvertently omitted. Dr Adi Gazdar served as the reference pathologist for interpretation of the bronchial biopsies and his name should have been
included in the author line. In addition, Table 2 of the same article contained errors. The corrected table is below. The errors have been noted in the online
version of the article, which is available at www.jto.org.
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